logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: ADHD
Load new posts () and activity
Like Reblog Comment
text 2016-08-26 08:39
ADHD Therapeutics Market are Factors Expected to Drive Revenue Growth by 2024

 

According to the latest market report published by Persistence Market Research, titled ‘Global ADHD Therapeutics Market: Continuous innovation by drug manufacturers and lucrative marketing strategies to fuel the demand for  ADHD Therapeutics during the forecast period (2015-2024)’, revenue from the global ADHD therapeutics market is expected to expand at a CAGR of 6.2% during forecast period 2015 - 2024.         

 

The market is segmented based on drug type, age group, distribution channel, and region. On the basis of drug type, the market has been broadly segmented into stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate) and non-stimulants (Atomoxetine, Bupropion, Guanfacine, and Clonidine). By drug type, the Lisdexamfetamine Dimesylate drug type sub-segment is expected to register highest CAGR of 15.6% in terms of value over the forecast period. The longer effectiveness of the treatment and easier availability is expected to contribute to its growing adoption. The Lisdexamfetamine Dimesylate drug type sub-segment is expected to reach a market value of US$ 5,682.2 Mn by 2024 end. Stimulants are expected to emerge as the most preferred drug type for both patients and physicians globally over the forecast period. The second-most popular drug type sub-segment is Amphetamine, expected to register a CAGR of 4.2% during the forecast period.

 

 Download Sample of this report @ http://www.persistencemarketresearch.com/samples/4222  

 

Rising prevalence of ADHD owing to the low threshold of diagnostic criteria, increasing awareness regarding ADHD, and shift from ICD-10 to DSM-IV are major factors driving the growth of the global ADHD therapeutics market currently. Other trends driving market growth are increasing concerns among parents and cultural differences towards ADHD, rising ADHD drug usage in adults, and novel drug development.

 

Generic drug manufacturers in the global ADHD therapeutics market are focusing on introducing cheaper and effective generic ADHD drugs to increase market share, the post-patent expiry of prescription drugs. Furthermore, adoption of alternative treatment methods and drug abuse are factors hampering the growth of this market.

 

This report assesses trends driving each market segments and sub-segments and offers analysis and insights into the potential of ADHD therapeutics therapies in specific regions. North America is estimated to dominate the global ADHD therapeutics market, with a maximum value share of the overall market by the end of 2016. By 2024, North America and Europe markets are expected to account for over four-fifths share of the global ADHD therapeutics market revenue. In terms of value, North America is estimated to be the dominant market, registering a CAGR of 5.9% over the forecast period.

 

 For more detailed information (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/attention-deficit-hyperactivity-disorder-therapeutics-market/toc  

 

Some key companies covered in this report include Eli Lilly and Company, Novartis AG, Shire PLC, Pfizer, Inc., GlaxoSmithKline PLC, Mallinckrodt Pharmaceuticals, Hisamitsu Pharmaceutical Co., Inc., Impax Laboratories, Inc., Johnson & Johnson, UCB S.A., and Purdue Parma L.P. These companies are primarily focused on enhancing their product portfolio through research and development and on introduction of innovative and cost-effective treatment procedures in order to gain higher market share and to strengthen their respective positions in the global market.

 

 Browse through the full Report at http://www.persistencemarketresearch.com/market-research/attention-deficit-hyperactivity-disorder-therapeutics-market.asp

 

About Us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our offerings include pre-built reports that address every major sale, customized solutions to cater to client-specific needs, and consulting services to offer more value addition. Our next-generation research approach for exploring emerging technologies has allowed us to solve the most complex problems of clients. We do not follow a reactive approach, but a pro-active one. Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and provide the latest insights into these technologies when they are being commercialized. Our ground-breaking approach allows us to deliver market solutions before the technologies reach the market.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

 

Contact Us:

Persistence Market Research

90 Sate Street, Suite 700 Albany, NY 12207

Tel: +1-518-618-1030

Email: sales@persistencemarketresearch.com

Website: http://www.persistencemarketresearch.com/

media@persistencemarketresearch.com

Stay updated with our official Blog: http://pmrblog.com

 

Source: www.persistencemarketresearch.com/market-research/attention-deficit-hyperactivity-disorder-therapeutics-market.asp
Like Reblog Comment
show activity (+)
review 2016-02-09 00:40
Ever wonder what it is like to be a parent to a child with ADHD?
The Boy from Hell: Life with a Child with ADHD - Alison M. Thompson

This is written by a mother of a boy with ADHD. She tells their story with honesty, and unless you have dealt with a child with the disorder you may find some of the things in this book hard to swallow. Parts of this brought tears to my eyes, others made me giggle. 

 

I have talked with parents who deal with children with ADHD a lot at work. They keep things back to themselves, but this woman tells all. She tells of the thoughts that flow through her mind as her child can't control himself, how the reaction you get from other parents is that of you being a bad parent and it being your fault that your child can't keep it together like the other kids. It is frustrating, I have seen the most wonderful parents have a child who just can't help himself or concentrate. 

 

This book would be a major help to anyone who read it, but I especially recommend it to parents who fond themselves in situation much like the author of this book foound herself in. This is story that needed to be told, I hope it gets the attention it deserves. There is so much understanding to be found in this book, and understanding is the key to heling children and parents who struggle with ADHD.

 

I recieved a copy of this through Edelwiess in exchange for an honest review. I plan to have the company I work for purchase copies. 

 

More posts
Your Dashboard view:
Need help?